Encore Medical and University of Colorado Health Sciences Center Announce Collaboration Agreement
30 Novembre 2005 - 1:00PM
PR Newswire (US)
AUSTIN, Texas, Nov. 30 /PRNewswire-FirstCall/ -- Encore Medical
Corporation (NASDAQ:ENMC) today announced that it has entered into
a multi- year collaboration agreement with The University of
Colorado at Denver Health Sciences Center (UCDHSC) covering
Encore's total joint and rehabilitation product lines. Under terms
of the agreement the parties will work to advance the state of the
science in the field of orthopedics through collaborative research
and education. The research will include, but not be limited to,
issues in orthopedic surgery, pain management and treatment of
orthopedic injuries. Encore will fund specific research projects to
be undertaken by the CU School of Medicine's Department of
Orthopaedics related to orthopedic health topics and will then have
access to the data and results of such research so as to better
design and develop its diverse product lines. "Developing a
long-term relationship with Encore will enable us to develop a
better product that will ultimately benefit our patients," said
Robert D. D'Ambrosia, MD, Chair of the CU School of Medicine's
Department of Orthopaedics. "We're confident that this partnership
will be a winning combination for all involved." "We are pleased to
collaborate with the University of Colorado on implant design,
image guided technologies in orthopedic surgeries, minimally
invasive techniques and instrumentation for orthopedic surgery,"
said Jack F. Cahill, Executive Vice-President and President of
Encore's Surgical Implant Division. "This exciting new ten-year
relationship promises to provide access to new technologies for our
product pipelines which we can use to deliver better devices for
the surgeons and physical therapists that use our products."
Kenneth W. Davidson, Encore's Chairman and Chief Executive Officer,
commented, "We believe that research will demonstrate the clinical
and economic benefits of our products that are used for the
orthopedic patient through the continuum of care, beginning
pre-surgery, and continuing through surgery and into post-surgery
rehabilitation. We think our efforts with the University of
Colorado should give us the data that will support our beliefs."
The School of Medicine faculty work to advance science and improve
care as the physicians, educators and scientists at University of
Colorado Hospital, The Children's Hospital, Denver Health Medical
Center, National Jewish Medical and Research Center and the
Veteran's Administration Medical Center. The School is part of the
University of Colorado at Denver and Health Sciences Center, one of
three campuses in the University of Colorado system. For more
information, visit the Web site at http://www.uchsc.edu/sm/sm/ .
Encore Medical Corporation is a diversified orthopedic device
company that develops, manufactures and distributes a comprehensive
range of high quality orthopedic devices, including surgical
implants, sports medicine equipment and products for orthopedic
rehabilitation, pain management and physical therapy. Based in
Austin, Texas, Encore's products are used by orthopedic surgeons,
physicians, therapists, athletic trainers and other healthcare
professionals to treat patients with musculoskeletal conditions
resulting from degenerative diseases, deformities, traumatic events
and sports-related injuries. Encore's non-invasive medical devices
and related accessories are primarily used by patients for at-home
physical therapy. Encore's Surgical Implant Division offers a
comprehensive suite of reconstructive joint products and spinal
implants. Through its Orthopedic Rehabilitation Division, Encore is
a leading manufacturer and distributor of orthopedic rehabilitation
equipment in the United States. For more information, visit
http://www.encoremed.com/ . Except for the historical information
contained herein, the matters discussed are forward-looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. These statements
involve risks and uncertainties, such as the timely availability of
new products, the impacts of competitive products and pricing, the
ability to grow the distribution networks for the Company's
products, the results of scientific research, and other risks and
uncertainties set forth in the Company's filings with the
Securities and Exchange Commission. These risks and uncertainties
could cause actual results to differ materially from any
forward-looking statements made herein. Contact: Harry L.
Zimmerman, Executive Vice President (512) 832-9500 Media: Davis
Henley, Vice President - Business Development (512) 832-9500
DATASOURCE: Encore Medical Corporation CONTACT: Harry L. Zimmerman,
Executive Vice President, +1-512-832-9500, or , or media, Davis
Henley, Vice President - Business Development, +1-512-832-9500, or
, both of Encore Medical Corporation Web site:
http://www.encoremed.com/ http://www.uchsc.edu/sm/sm
Copyright
Grafico Azioni Encore Medical (NASDAQ:ENMC)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Encore Medical (NASDAQ:ENMC)
Storico
Da Set 2023 a Set 2024